DIAGNOSTICS
At YouMed, we are able to plug in to the upstream development of instrumentation so that real-time feedback from key audiences can support the development direction of your products, and we can follow that through to commercial execution and placement of your first orders.
As a team we aspire to be a key supplier and distributor of the most innovative, disruptive diagnostics and devices in the UK. We understand the pressures faced by the National Health Service, the strict regulatory frameworks, and the need for high performance products to support clinical diagnostic settings.
Using our years of experience in this space and our extensive network of key clinicians, we scrutinise every product for viability and effectiveness before committing to a commercial promise of successful distribution through our expert field-based teams. We guarantee to get your product in front of the people who will be empowered by its use.
Molecular Diagnostics
Clinical and molecular diagnostic laboratories need the most precise and reliable assays and products. Every step of the molecular diagnostics workflow, whether it is DNA purification, PCR, mutation detection or testing for biomarkers such as microsatellite instability, requires rigorous quality and robust molecular tools and products. Our team has significant experience developing, commercialising, launching and promoting Molecular Diagnostic solutions for companies within the UK healthcare market. Although Molecular Diagnostics is the gold standard for certain clinical areas such as Virology, other disciplines are slow to uptake these products. We understand what is required for commercial traction, (reference labs, HEOR data, clinical algorithms etc.) and will work with our clients to ensure success.
Point of Care
Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates better disease diagnosis, monitoring, and management. It enables quick medical decisions, as the diseases can be diagnosed at a very early stage, leading to improved health outcomes for patients by enabling the early start of treatment. YouMed truly believes POCT is the future of diagnostics in healthcare institutions under intense pressure to improve efficiency and flow of patients through overcrowded and strained healthcare systems.
Haematology
The channel of medicine associated with the origin, diagnosis, therapy, and anticipation of diseases related to blood. This clinical speciality comprises treating diseases that mark the production of blood and its components, for example blood cells, blood proteins, bone marrow, haemoglobin, platelets, spleen, blood vessels and the method of coagulation. Such ailments might embrace hemophilia, blood clots, added bleeding disorders and blood cancers such as leukaemia, lymphoma and multiple myeloma. The YouMed team has significant experience in the promotion of both established technologies as well as new disruptive products within this area.
Companion Diagnostics
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The various tests help health care professionals determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.
Companion diagnostics can:
• identify patients who are most likely to benefit from a particular therapeutic product;
• identify patients likely to be at increased risk for serious side effects as a result of treatment with a particular therapeutic product; or
• monitor response to treatment with a particular therapeutic product for the purpose of adjusting treatment to achieve improved safety or effectiveness.
If the diagnostic test is inaccurate, then the treatment decision based on that test may not be optimal.
